Skip to main content
Year archive

Valneva SE — 2019 filings

All 86 regulatory filings released by Valneva SE (VLA) in 2019, sourced directly from the official regulator.

86 Filings
2019 Period
2019 filings (86)
Filing Released Lang
Valneva Appoints MVM Partner Thomas Casdagli to its Supervisory Board
Board/Management Information
2019-12-12 English
Valneva nomme Thomas Casdagli, Associé de la société MVM, à son Conseil de Surveillance
Board/Management Information
2019-12-12 French
Valneva annonce la nomination des spécialistes des vaccins Stanley Plotkin et Anna Durbin à son Conseil Scientifique
Board/Management Information
2019-12-09 French
Valneva Appoints Renowned Vaccinologists Stanley Plotkin and Anna Durbin to its Scientific Advisory Board
Board/Management Information
2019-12-09 English
Valneva to Conduct Investor and Partnering Meetings during the 38th Annual J.P. Morgan Healthcare Conference
Investor Presentation
2019-12-05 English
Valneva rencontrera investisseurs et partenaires potentiels lors de la 38ème J.P. Morgan Healthcare Conference
Investor Presentation
2019-12-05 French
Valneva : l’EMA approuve une prolongation de la durée d’utilisation du vaccin IXIARO® à 36 mois
Regulatory Filings
2019-11-28 French
Valneva Announces EMA Approval of IXIARO® Shelf Life Extension to 36 Months
Regulatory Filings
2019-11-28 English
Valneva Reports Excellent Final Phase 1 Results for its Chikungunya Vaccine Candidate, Confirms Plans
Earnings Release FY 2019
2019-11-18 English
Valneva publie d’excellents résultats finaux de Phase 1 pour son candidat vaccin contre le chikungunya
Earnings Release FY 2019
2019-11-18 French
Valneva annonce la nomination de deux experts des vaccins à son Conseil Scientifique
Board/Management Information
2019-11-13 French
Valneva Announces Appointments of Two Leading Vaccine Experts to its Scientific Advisory Board
Board/Management Information
2019-11-13 English
Déclaration d'actions et de droits de vote de la société Valneva SE - Octobre 2019
Declaration of Voting Results & Voting Rights Announcements
2019-11-06 French
Valneva Raises Product Sales Guidance Following Strong Nine-Month Results and R&D Execution
Interim / Quarterly Report FY 2019
2019-10-31 English
Valneva révise en hausse sa prévision de croissance des ventes de produits pour 2019 suite à de bons résultats sur les neuf premiers mois de l’exercice, et confirme la bonne exécution de ses programme
Interim / Quarterly Report FY 2019
2019-10-31 French
Valneva: Recrutement terminé pour les études de Phase 2 du candidat vaccin contre la maladie de Lyme VLA15
Regulatory Filings
2019-09-30 French
Valneva Completes Recruitment for Phase 2 Studies of its Lyme Disease Vaccine Candidate VLA15
Investor Presentation
2019-09-30 English
Valneva: Recrutement terminé pour les études de Phase 2 du candidat vaccin contre la maladie de Lyme VLA15
Regulatory Filings
2019-09-30 French
Valneva Completes Recruitment for Phase 2 Studies of its Lyme Disease Vaccine Candidate VLA15
Legal Proceedings Report
2019-09-30 English
Valneva confirme le retrait de ses actions de la Bourse de Vienne
Delisting Announcement
2019-09-19 French
Valneva Confirms Delisting from the Vienna Stock Exchange
Delisting Announcement
2019-09-19 English
Valneva Confirms Delisting from the Vienna Stock Exchange
Delisting Announcement
2019-09-19 English
Valneva Confirms Delisting from the Vienna Stock Exchange
Delisting Announcement
2019-09-19 English
Valneva confirme le retrait de ses actions de la Bourse de Vienne
Delisting Announcement
2019-09-19 French
Valneva confirme le retrait de ses actions de la Bourse de Vienne
Delisting Announcement
2019-09-19 French
Valneva Confirms Delisting from the Vienna Stock Exchange
Delisting Announcement
2019-09-19 English
Valneva confirme le retrait de ses actions de la Bourse de Vienne
Delisting Announcement
2019-09-19 French
Valneva annonce l'acquisition d'actions par son Directoire
Director's Dealing
2019-08-19 French
Valneva annonce l'acquisition d'actions par son Directoire
Director's Dealing
2019-08-19 French
Valneva Announces Management Board Stock Purchases
Director's Dealing
2019-08-19 English
Valneva annonce l'acquisition d'actions par son Directoire
Director's Dealing
2019-08-19 French
Valneva annonce l'acquisition d'actions par son Directoire
Director's Dealing
2019-08-19 French
Valneva annonce l'acquisition d'actions par son Directoire
Director's Dealing
2019-08-19 French
Valneva Announces Management Board Stock Purchases
Director's Dealing
2019-08-19 English
Valneva Announces Management Board Stock Purchases
Director's Dealing
2019-08-19 English
Valneva Announces Management Board Stock Purchases
Director's Dealing
2019-08-19 English
Valneva Announces Management Board Stock Purchases
Director's Dealing
2019-08-19 English
Valneva annonce l'acquisition d'actions par son Directoire
Director's Dealing
2019-08-19 French
Déclaration d'actions et de droits de vote de la société Valneva SE - Juillet 2019
Declaration of Voting Results & Voting Rights Announcements
2019-08-01 French
Valneva rapport semestriel 2019
Interim / Quarterly Report H1 2019
2019-08-01 French
Valneva: résultats financiers du S1 2019 soutenus par une forte performance opérationnelle et des avancées majeures
Earnings Release H1 2019
2019-08-01 French
Valneva Reports H1 2019 Results Marked by Strong Operational Performance and Major Corporate Progress
Earnings Release H1 2019
2019-08-01 English
Déclaration d'actions et de droits de vote de la société Valneva SE - Juin 2019
Declaration of Voting Results & Voting Rights Announcements
2019-07-11 French
Bilan Semestriel du contrat de liquidité de Valneva SE
Share Issue/Capital Change
2019-07-09 French
Valneva: Renowned Vaccinologist Dr. Stanley Plotkin to Present at R&D Investor Day in New York City on July 9th
Report Publication Announcement
2019-07-03 English
Le Dr. Stanley Plotkin, spécialiste mondial des vaccins, participera à la journée investisseurs consacrée à la R&D de Valneva le 9 juillet à New York
Report Publication Announcement
2019-07-03 French
Valneva dépose une demande de radiation de ses actions ordinaires auprès de la bourse de Vienne
Delisting Announcement
2019-07-02 French
Valneva Submits Delisting Application to the Vienna Stock Exchange
Delisting Announcement
2019-07-02 English
Valneva initie la deuxième étude de Phase 2 pour son candidat vaccin contre la maladie de Lyme VLA15
Regulatory Filings
2019-07-01 French
Valneva Initiates Second Phase 2 Study for its Lyme Disease Vaccine Candidate VLA15
Regulatory Filings
2019-07-01 English
Valneva Shareholders Approve all Resolutions Recommended by the Management Board at the Annual General Meeting
AGM Information
2019-06-28 English
Les actionnaires de Valneva approuvent toutes les résolutions recommandées par le directoire à l’Assemblée Générale du Groupe
AGM Information
2019-06-28 French
Voltalia SA : SNCF Energie et Voltalia signent le premier contrat d'achat direct d'électricité renouvelable de près de 150 mégawatts et de très longue durée en France
Regulatory Filings
2019-06-26 French
Voltalia SA: SNCF Energie and Voltalia sign a very long-term direct power purchase agreement of nearly 150 MW, a first in France
Environmental & Social Information
2019-06-26 English
Voltalia franchit le cap du gigawatt installé ou en construction
Regulatory Filings
2019-06-13 French
Voltalia crosses the 1 GW in operation or construction milestone
Regulatory Filings
2019-06-13 English
Valneva Reports Successful Outcome of Phase 2 Run-In for its Lyme Disease Vaccine Candidate
Regulatory Filings
2019-06-12 English
Valneva annonce le succès de la première étape de Phase 2 pour son vaccin contre la maladie de Lyme
Investor Presentation
2019-06-12 French
VALNEVA fera un point sur l’avancée de ses programmes de vaccins Lyme et chikungunya le 9 juillet à New York lors d’une journée investisseurs consacrée à la R&D
Regulatory Filings
2019-06-11 French
Valneva to Present Lyme Disease and Chikungunya Vaccine Updates at R&D Investor Day in New York City on July 9th
Regulatory Filings
2019-06-11 English
2019_06_06_VLA_Availability_of_AGM_documents_PR_FR
AGM Information
2019-06-06 French
2019_05_22_VLA_Chik_Results_PR_FR
Regulatory Filings
2019-05-22 French
2019_05_22_VLA_Chik_Results_PR_EN
Earnings Release FY 2019
2019-05-22 English
Déclaration d'actions et de droits de vote Avril 2019 - Valneva
Declaration of Voting Results & Voting Rights Announcements
2019-05-06 French
2019_05_02_VLA_Q1_Results_PR_FR
Earnings Release Q1 2019
2019-05-02 French
2019_05_02_VLA_Q1_Results_PR_EN
Earnings Release Q1 2019
2019-05-02 English
2019_04_06_VLA_WorldVaccineCongress_PR_EN
Regulatory Filings
2019-04-09 English
2019_04_06_VLA_WorldVaccineCongress_PR_FR
Regulatory Filings
2019-04-09 French
2019_04_03_VLA_Shareholder_Agreement_PR_FR
Major Shareholding Notification
2019-04-03 French
2019_03_26_VLA_2018_Registration_Document_PR_FR
Report Publication Announcement
2019-03-26 French
Déclaration d'actions et droits de vote fevrier 2019 - Valneva SE
Declaration of Voting Results & Voting Rights Announcements
2019-03-04 French
Franchissement de seuil et déclaration d'intention
Major Shareholding Notification
2019-03-01 French
2019_02_21_VLA_FY2018_Unaudited_Results_PR_FR
Earnings Release FY 2018
2019-02-21 French
2019_02_21_VLA_FY2018_Unaudited_Results_PR_EN
Earnings Release FY 2018
2019-02-21 English
2019_01_31_VLA15_FinalPh1_&_Initial_Booster_Data.FR
Earnings Release Q1 2019
2019-01-31 French
2019_01_31_VLA15_FinalPh1_&_Initial_Booster_Data.EN
Earnings Release Q1 2019
2019-01-31 English
Franchissements de seuils
Major Shareholding Notification
2019-01-29 French
2019_01_16_VLA_Guidance_PR_EN
Earnings Release FY 2018
2019-01-16 English
2019_01_16_VLA_Guidance_PR_FR
Earnings Release FY 2018
2019-01-16 French
2019_01_16_VLA_DoD_Contract_PR_EN
Regulatory Filings
2019-01-16 English
2019_01_16_VLA_DoD_Contract_PR_FR
Legal Proceedings Report
2019-01-16 French
2019_01_07_VSE_Delisting_PR_EN.pdf
Delisting Announcement
2019-01-07 English
2019_01_07_VSE_Delisting_PR_FRA.pdf
Delisting Announcement
2019-01-07 French
2019_01_07_VLA_Chik_Ph1_Results_PR_EN
Earnings Release FY 2019
2019-01-07 English
2019_01_07_VLA_Chik_Ph1_Results_PR_FR
Earnings Release FY 2019
2019-01-07 French
Bilan Semestriel - Valneva SE
Report Publication Announcement
2019-01-04 French